NCT05729061 Analysis of Human Movement With Assistive Devices
| NCT ID | NCT05729061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Orthocare Innovations, LLC |
| Condition | Limb Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-11-28 |
| Primary Completion | 2024-11-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-11-28 with a primary completion date of 2024-11-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies. Individuals that have limb weakness, limb paralysis, limb loss, and movement disorders are often provided assistive devices such as prostheses and orthoses to assist with mobility or use assistive technologies for purposes such as to regain muscle strength or retrain movements. It is important to understand the impact of these different assistive technologies on human movement for technology improvement and in preparation for commercialization. Because this research focuses on evaluating how different people move about in different settings with different assistive devices/components, there are different activities that may take place. These activities have been classified as (1) Movement Analysis in the Laboratory, (2) Movement Analysis Outside the Laboratory, (3) Usability Testing, and (4) Focus Groups. Each participant may or may not complete the same activities as the other participants. Each participant may or may not complete all of the activities. Participants may complete the activities more than once.
Eligibility Criteria
Inclusion Criteria for Nondisabled Participants: * Age 18 - 90 years * Has bilateral normal range of motion * Able to perform a variety of movement activities * Able to communicate and write individual perceptions in English * Able to provide written informed consent * Participants that will use a treadmill during data collection must also be able to walk independently and safely on a treadmill Exclusion Criteria for Nondisabled Participants: * Health issues (e.g., confounding injury, musculoskeletal, or cognitive) or other issues (e.g., transportation or schedule issues) that limit effective participation and/or may not represent a nondisabled condition * Pregnancy * Not able to read and understand English Inclusion Criteria for Participants with a Disability: * Age 18 - 90 years * Has a condition or diagnosis that results in limb weakness, limb paralysis, limb loss, or movement disorders * Medically stable * Has stable balance * Able to perform a variety of movement activities * Able to communicate and write individual perceptions in English * Able to provide written informed consent * Participants that will use a treadmill during data collection must also be able to walk independently and safely on a treadmill * Able to safely complete the movements being tested and/or safely use the assistive devices being tested Exclusion Criteria for Participants with a Disability: * Health issues (e.g., confounding injury, musculoskeletal, or cognitive) or other issues (e.g., transportation or schedule issues) that limit effective participation and/or may result in mixed effects of multiple sources of disability * Pregnancy * Not able to read and understand English
Contact & Investigator
Adam Arabian, PhD
PRINCIPAL INVESTIGATOR
Orthocare Innovations, LLC
Frequently Asked Questions
Who can join the NCT05729061 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Limb Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05729061 currently recruiting?
Yes, NCT05729061 is actively recruiting participants. Contact the research team at arabian@orthocareinnovations.com for enrollment information.
Where is the NCT05729061 trial being conducted?
This trial is being conducted at Edmonds, United States.
Who is sponsoring the NCT05729061 clinical trial?
NCT05729061 is sponsored by Orthocare Innovations, LLC. The principal investigator is Adam Arabian, PhD at Orthocare Innovations, LLC. The trial plans to enroll 100 participants.